Andrea Perrone
Università Cattolica del Sacro Cuore(IT)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Management, Economics, and Public Policy, Immunotherapy and Immune Responses, Legal and Labor Studies, Corporate Governance and Law
Most-Cited Works
- → iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics(2017)2,331 cited
- → Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab(2016)741 cited
- → Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab(2018)305 cited
- → Peripheral blood gene expression profiling in rheumatoid arthritis(2005)153 cited
- → Epigenetic Multiple Ligands: Mixed Histone/Protein Methyltransferase, Acetyltransferase, and Class III Deacetylase (Sirtuin) Inhibitors(2008)132 cited
- → Measurement of Tumor Volumes Improves RECIST-Based Response Assessments in Advanced Lung Cancer(2012)111 cited
- → Innovative Poly (Vinylidene Fluoride) (PVDF) Electrospun Nanofiber Membrane Preparation Using DMSO as a Low Toxicity Solvent(2020)88 cited
- → Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST(2020)70 cited
- → Synthesis and Biological Validation of Novel Synthetic Histone/Protein Methyltransferase Inhibitors(2007)56 cited
- → Design and conduct of early clinical studies of immunotherapy agent combinations: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies(2018)42 cited